Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Danner

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 24, 2025
Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trialMelanie Arnreiter, Moritz von Scheidt, Johannes M Albes, et al.
Cardiovascular Research|April 3, 2026
Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patientsAiste Liutkute, Takiy-Eddine Berrandou, Stefanie Kestel, et al.
Circulation|June 24, 2024
Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial FibrillationFunsho E Fakuade, Dominik Hubricht, Vanessa Möller, et al.
American Heart Journal|September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trialAntoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 17, 2024
The ROMA trial: 7 years of trial activities and the development of the ROMA trial networkMario Gaudino, Massimo Lemma, Sigrid Sandner, et al.
EMBO Molecular Medicine|August 12, 2018
Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasisHanibal Bohnenberger, Lars Kaderali, Philipp Ströbel, et al.
Circulation Research|October 15, 2025
Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial FibrillationJulius Ryan D Pronto, Fleur E Mason, Eva A Rog-Zielinska, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 24, 2025
Extent of coronary artery disease and clinical outcomes with ticagrelor monotherapy versus aspirin after coronary artery bypass grafting: insights from the TiCAB trialMelanie Arnreiter, Moritz von Scheidt, Johannes M Albes, et al.
Cardiovascular Research|April 3, 2026
Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patientsAiste Liutkute, Takiy-Eddine Berrandou, Stefanie Kestel, et al.
Circulation|June 24, 2024
Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial FibrillationFunsho E Fakuade, Dominik Hubricht, Vanessa Möller, et al.
American Heart Journal|September 7, 2016
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trialAntoinette de Waha, Sigrid Sandner, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2022
Prognostic impact of secondary prevention after coronary artery bypass grafting-insights from the TiCAB trialTobias Heer, Moritz von Scheidt, Andreas Boening, et al.
European Heart Journal|May 31, 2019
Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trialHeribert Schunkert, Andreas Boening, Moritz von Scheidt, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 17, 2024
The ROMA trial: 7 years of trial activities and the development of the ROMA trial networkMario Gaudino, Massimo Lemma, Sigrid Sandner, et al.
EMBO Molecular Medicine|August 12, 2018
Comparative proteomics reveals a diagnostic signature for pulmonary head-and-neck cancer metastasisHanibal Bohnenberger, Lars Kaderali, Philipp Ströbel, et al.
Circulation Research|October 15, 2025
Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial FibrillationJulius Ryan D Pronto, Fleur E Mason, Eva A Rog-Zielinska, et al.
Pageof 10